$NDEV Novus Cannabis Medplan Unveils Game-Changing Platform

New Post Public Reply Private Reply Replies (0) Message Board
louied91
87
$NDEV Novus Cannabis Medplan Unveils Game-Changing Platform for Direct Consumer Access and Cost-Free Solutions for Cannabis Businesses

https://www.otcmarkets.com/stock/NDEV/news/No...?id=466668

Novus Acquisition & Development Corp, operating as Novus Cannabis MedPlan (OTC: NDEV), is a leading national carrier of supplemental health insurance plans and a pioneer in incorporating cannabis coverage for recreational and medicinal users. Proudly announces the launch of its innovative direct-to-consumer (D2C) and policyholder platform for cannabis businesses at no cost.



Ancillary cannabis businesses, such as Novus, provide a niche opportunity, even in the absence of federal legalization. Investors should research the compliance of health insurance and healthcare plans that offer cannabis coverage as a compliant form of cannabis distribution without handling the plant directly.



This innovative platform makes cannabis access easier for medical and recreational users through a comprehensive mobile app and computer interface. Unlike competing platforms that charge over $1,000 monthly, cannabis businesses receive this service for free. This approach promotes growth and enables seamless transactions.



The Novus platform offers a multitude of benefits for Novus Providers, including:

Exclusive Customer Acquisition: Novus has a dedicated team of 2,500 agents nationwide who focus on driving customers to purchase policies and direct that traffic to cannabis businesses, ensuring a steady influx of new clientele.

Competitive Advantage: Exclusive access to territory enables cannabis businesses and brands to differentiate themselves from competitors and capture a larger market share.

Flexible Reimbursement Options: Benefit from various reimbursement options tailored to cannabis business needs as an additional revenue stream.

Seamless Integration: The platform seamlessly integrates with existing workflows, supporting inventory control triggers and delivery options without disrupting daily operations.

Revenue Optimization: Novus generates revenue solely from policy premiums, enabling cannabis businesses to retain 100% of their sales revenue.

Advanced Inventory Management: The integrated Inventory Control feature allows dispensaries to set minimum quantity triggers for products. Automated notifications alert staff when the stock falls below these thresholds, ensuring timely reordering and preventing stockouts.

Streamlined Delivery Management: For businesses offering delivery services, the Deliveries tab simplifies consumer transfers, integrates with inventory control, and provides detailed delivery logs for enhanced tracking and accountability.

Novus Cannabis MedPlan is committed to empowering the cannabis industry with cutting-edge technology and comprehensive support. By connecting consumers and policyholders with dispensaries or brands and providing businesses with the free tools they need to succeed, Novus is shaping the future of cannabis commerce.



Conclusion

The Novus D2C and policyholder platform significantly advance the cannabis industry. It offers unparalleled consumer and business benefits. By providing free access to this powerful platform, Novus Cannabis MedPlan demonstrates its commitment to fostering growth and innovation within the cannabis sector.

Novus Acquisition & Development Corp. (NDEV) Stock Research Links

NDEV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 208

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 155

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 61

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 309

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 526

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 48

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 809

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 144

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 555

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 105

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading

Top 5 Most Recently Viewed Articles

Join the Walk for Kids in Support of Hospitalized Families

Updated Category News Views 165

Join the Walk for Kids in Support of Hospitalized Families On April 12, 2025, a significant event will take place that aims to support families with children requiring medical care. The Ronald McDonald House Orange County (RMHOC) proudly presents its 16th Annual Walk for Kids at the Championship Soccer Stadium. This community-driven event is structured to bring together...

Continue Reading
CNOOC Limited's Mero3 Project Enters Production Phase Successfully

Updated Category News Views 102

CNOOC Limited's Mero3 Project Achieves Production Milestone CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) proudly announces that its Mero3 Project has safely commenced production. This achievement marks a significant step in CNOOC's ongoing efforts to enhance its capabilities within the offshore oil and gas sector....

Continue Reading
YFORE's ODMS: A Leap in Vehicle Cabin Safety

Updated Category News Views 82

A New Era for In-Cabin Monitoring There's a fresh scent in the Suwanee air, and it's coming from YFORE Technology's newly minted North American manufacturing digs in Georgia. You'd think it's just another plant popping up, right? But here's where things get spicy—YFORE has rolled out the Occupant & Driver Monitoring System (ODMS). This isn't your vanilla monitoring...

Continue Reading
Investors Take Action: Nextracker Class Action Update

Updated Category News Views 131

Important Action for Nextracker Investors Kahn Swick & Foti, LLC (KSF) has important information for investors in Nextracker Inc. If you have experienced losses exceeding $100,000, your time to act is critical. You have until a specific deadline to submit an application as a lead plaintiff in a class-action lawsuit concerning the company's securities. Understanding Your...

Continue Reading
Four Seasons Yachts Announces Exciting Caribbean Holiday Sailings

Updated Category News Views 145

New Holiday Itineraries for Four Seasons Yachts Four Seasons Yachts is thrilled to unveil a stunning selection of holiday voyages for the 2026-2027 season, marking the end of its first year of sailing. With nine new voyages and 17 captivating destinations, the company is dedicated to creating unforgettable experiences on the water. Imagine celebrating the holidays...

Continue Reading